About this trial
The goal of this clinical trial is to explore the effects of the system-integrated technology-enabled model of care in ischemic stroke patients with dysphagia. The main question it aims to answer is: Can one-year system-integrated technology-enabled model of care improve the incidence of aspiration pneumonia, swallowing function, nutritional status, self-care ability, and quality of life among post-discharge ischemic stroke patients with dysphagia.
Researchers will compare system-integrated technology-enabled model group and control group to see if there are significant intergroup differences in the incidence of aspiration pneumonia, swallowing function, nutritional status, self-care ability, and quality of life.
Participants will be divided into the system-integrated technology-enabled model group and the control group. Participants in the system-integrated technology-enabled model group will receive support and follow-up services for dysphagia management, as well as physician-patient communication, with the assistance of mobile phones for one year. Participants in the control group will receive routine management.
Eligibility criteria
Qualifiers
discharged ischemic stroke survivors
disease duration ≤3 months
Dysphagia Outcome and Severity Scale grade ranging 1-5 levels.
stable vital signs, out of the acute phase, and not requiring long-term bed rest and monitoring.
Disqualifiers
expected lifespan ≤1 year
other severe systemic diseases.
participating in other clinical trials.
severe cognitive or psychiatric disorders, or severe aphasia.
Trial design
Treatments tested in this trial
- System-integrated Technology-enabled Model of Care
Treatment groups
Locations
Sponsors and collaborators
Zeng Xi
Lead sponsor
People's Hospital of Zhengzhou University
Sponsor institution